Alaunos Therapeutics, Inc. Postemployment Benefits, Period Expense
Alaunos Therapeutics, Inc. (TCRT) reported Postemployment Benefits, Period Expense of $3.50 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PostemploymentBenefitsPeriodExpense · last filed 2021-11-08
- 2021-09-30: Postemployment Benefits, Period Expense 9 month $3.50M.
| Period end | Postemployment Benefits, Period Expense 9 month |
|---|---|
| 2021-09-30 | $3.50M 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |